Guertin, Marie-Claude

Efficacy and safety of low-dose colchicine after myocardial infarction

Tardif, J.-C., Kouz, S., Waters, D. D., Bertrand, O. F., Diaz, R., Maggioni, A. P., Pinto, F. J., Ibrahim, R., Gamra, H., Kiwan, G. S., et al. (2019) · New England Journal of Medicine

Acute Myocardial Infarction ResearchCardiac Fibrosis and Remodeling

Cited by 3,159

Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease

Diaz, A., Bourassa, M. G., Guertin, M.-C., & Tardif, J.-C. (2005) · European Heart Journal

Heart rate and cardiovascular healthHeart Rate Variability and Autonomic Control

Cited by 790

Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial

Lespérance, F., Frasure-Smith, N., Koszycki, D., Laliberté, M.-A., van Zyl, L. T., Baker, B., Swenson, J. R., Ghatavi, K., Abramson, B. L., Dorian, P., et al. (2007) · JAMA

Cardiac Health and Mental HealthTreatment of Major Depression

Cited by 658

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

Tardif, J.-C., Ballantyne, C. M., Barter, P., Dasseux, J.-L., Fayad, Z. A., Guertin, M.-C., Kastelein, J. J. P., Keyserling, C., Klepp, H., Koenig, W., et al. (2014) · European Heart Journal

Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cited by 251

Prevalence of and risk factors for persistent postoperative nonanginal pain after cardiac surgery: a 2-year prospective multicentre study

Choinière, M., Watt-Watson, J., Victor, J. C., Baskett, R. J. F., Bussières, J. S., Carrier, M., Cogan, J., Costello, J., Feindel, C., Guertin, M.-C., et al. (2014) · Canadian Medical Association Journal

Anesthesia and Pain ManagementCardiac and Coronary Surgery Techniques

Cited by 206